[t4b-ticker]

Tilly’s (TLYS) Q4 Earnings: What To Expect

Share:
Tilly's (TLYS) Q4 Earnings: What To Expect
Tilly’s (TLYS) Q4 Earnings: What To Expect

Young adult apparel retailer Tilly’s (NYSE:TLYS)
will be reporting results tomorrow after market hours. Here’s what to expect.

Last quarter Tilly’s (NYSE:) reported revenues of $166.5 million, down 6.4% year on year, missing analyst expectations by 1%. It was a weak quarter for the company, with same-store sales coming in below expectations, leading to a revenue miss. Looking ahead, while next quarter’s revenue guidance was fine, EPS guidance came in below expectations, suggesting weaker margins.

Is Tilly’s buy or sell heading into the earnings? Find out by reading the original article on StockStory.

This quarter analysts are expecting Tilly’s’s revenue to decline 4.8% year on year to $171.7 million, improvement on the 11.8% year-over-year decrease in revenue the company had recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.22 per share.

Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company missed Wall St’s revenue estimates three times over the last two years.

Looking at Tilly’s’s peers in the apparel retailer segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. Gap delivered top-line growth of 1.3% year on year, beating analyst estimates by 1.7% and Abercrombie and Fitch (NYSE:) reported revenues up 21.1% year on year, exceeding estimates by 1.5%. Gap traded up 9.2% on the results, and Abercrombie and Fitch was flat on the results.

Read the full analysis of Gap’s and Abercrombie and Fitch’s results on StockStory.

There has been positive sentiment among investors in the apparel retailer segment, with the stocks up on average 5.3% over the last month. Tilly’s is down 3.1% during the same time, and is heading into the earnings with analyst price target of $8.6, compared to share price of $7.19.